Lab result explainedBlood count (CBC)Last updated November 11, 2026

Coombs test: what a positive direct or indirect antiglobulin test means

Coombs test (direct and indirect antiglobulin test) (DAT / IAT) · Hemolysis work-up, prenatal antibody screen, pre-transfusion testing, newborn cord blood testing · reported in Reported as negative or positive; positive direct tests are graded w+ (weak), 1+, 2+, 3+ or 4+ and typed as IgG, C3d or both; indirect tests report the antibody identified and a titer (for example 1:16)

The Coombs test, now usually called the antiglobulin test, looks for antibodies that target red blood cells. There are two versions. The direct Coombs test (direct antiglobulin test, DAT) checks whether antibodies or complement proteins are already stuck to the surface of your own red cells, which is the hallmark of immune hemolysis. The indirect Coombs test (indirect antiglobulin test, IAT, also called the antibody screen) checks whether your plasma contains antibodies that could attack red cells carrying antigens you lack, which matters before a transfusion and during pregnancy. The normal result for both is negative.

A positive direct Coombs test in an adult most often means autoimmune hemolytic anemia, a reaction to a medicine, or a delayed reaction to a recent transfusion, and it is read alongside haptoglobin, LDH, bilirubin and a reticulocyte count to see whether red cells are actually being destroyed. A positive direct Coombs test in a newborn usually means the mother's antibodies have crossed the placenta and coated the baby's cells, most commonly because of an ABO mismatch (an O mother with an A or B baby) or, less often now, Rh incompatibility; the practical consequence is a higher risk of jaundice in the first days of life.

A positive indirect Coombs test in pregnancy means the mother has made an antibody against a red cell antigen, usually from a previous pregnancy or transfusion. Most such antibodies are harmless, some (anti-D, anti-K, anti-c) can cause hemolytic disease of the fetus, and the antibody is identified and its strength (titer) followed through the pregnancy. A positive test does not by itself mean anything is wrong with the baby, and a weakly positive screen after a routine Rh immunoglobulin injection is expected.

DAT / IAT at a glance

What it is: the direct test (DAT) detects antibody or complement already bound to your red cells; the indirect test (IAT, antibody screen) detects free antibodies in your plasma against red cell antigens.
Normal: negative for both. A positive DAT is graded weak (w+) to 4+; a positive IAT is followed by antibody identification and, in pregnancy, a titer.
Positive direct Coombs in adults: autoimmune hemolytic anemia (warm IgG or cold complement type), drug-induced hemolysis, a transfusion reaction, or an incidental finding; about 1 in 1,000 to 1 in 14,000 healthy donors and 1 to 15 percent of hospital patients test positive without hemolysis.
Positive direct Coombs in a newborn: maternal antibodies on the baby's cells, usually ABO or Rh incompatibility; it raises the risk of significant jaundice, so bilirubin is monitored closely.
Positive indirect Coombs in pregnancy: a red cell antibody that may or may not affect the baby; anti-D titers of 1:16 or more (or any anti-K) trigger closer fetal monitoring. Rh immunoglobulin given at 28 weeks causes a weak, harmless positive.
Next step: confirm whether hemolysis is happening (hemoglobin, haptoglobin, LDH, bilirubin, reticulocytes, smear), review medicines and transfusions, and identify the antibody.

Have your whole report? Paste it into the free Lab Explainer

Every marker explained in plain language, in context with the others, with questions to bring to your appointment. No account needed.

What DAT / IAT measures

Antibodies that coat red cells (mostly IgG) and complement fragments (C3d) do not by themselves clump cells together in a test tube. Robin Coombs's 1945 insight was to add an antibody against human antibodies and complement, the antihuman globulin reagent, which bridges coated cells and makes them agglutinate visibly. For the direct test, your washed red cells are mixed with the reagent; agglutination means the cells were already coated inside your body. The lab grades the reaction from weakly positive (w+, sometimes only visible under the microscope) through 1+ to 4+, and a positive result is then repeated with separate anti-IgG and anti-C3d reagents to show which is present, which narrows the cause.

For the indirect test, your plasma is first incubated with a panel of reagent red cells of known antigen types, giving any antibodies present time to bind, and antihuman globulin is then added. A positive screen is followed by a panel of 10 or more cell types to identify exactly which antigen the antibody targets (anti-D, anti-K, anti-E, anti-Fya and so on), and in pregnancy by a titer, the highest dilution of plasma that still reacts, reported as 1:4, 1:16 and so on. The same indirect method is the basis of the pre-transfusion antibody screen and crossmatch.

The test is qualitative and reports presence, not quantity of hemolysis. Strongly positive results are more likely to go with clinical hemolysis, but 4+ results occur without any red cell destruction and weak results occur with brisk hemolysis; and 5 to 10 percent of autoimmune hemolytic anemia is DAT-negative because the antibody is below the detection limit or is IgA or IgM. Results are affected by recent transfusion, intravenous immunoglobulin, Rh immunoglobulin, some monoclonal antibody drugs and high serum globulin levels, so the blood bank needs an accurate history.

Normal range for DAT / IAT

Reference ranges vary between labs and by age, sex and pregnancy. Use the range printed on your own report.

Group	Typical range (Reported as negative or positive; positive direct tests are graded w+ (weak), 1+, 2+, 3+ or 4+ and typed as IgG, C3d or both; indirect tests report the antibody identified and a titer (for example 1:16))	Notes
Direct Coombs (DAT), negative	No agglutination	The expected result. Does not fully exclude immune hemolysis: 5 to 10 percent of autoimmune hemolytic anemia is DAT-negative.
DAT, weak positive (w+ or microscopic)	Agglutination visible only on close inspection or microscopy	Common and often clinically silent: after Rh immunoglobulin, IVIG, in hospital patients with high globulins, and in some healthy donors. Needs hemolysis markers to interpret.
DAT, 1+ to 2+	Small to medium clumps	Typical of ABO hemolytic disease of the newborn, drug-induced antibodies and many cases of warm autoimmune hemolytic anemia.
DAT, 3+ to 4+	Large clumps or one solid agglutinate	Typical of Rh hemolytic disease of the newborn, acute hemolytic transfusion reactions and florid autoimmune hemolysis, though strength does not reliably predict how fast cells are being destroyed.
DAT typing: IgG only or IgG plus C3d	Positive with anti-IgG reagent	Warm autoimmune hemolytic anemia (about 70 to 80 percent of autoimmune cases), drug antibodies, alloantibodies after transfusion, hemolytic disease of the newborn.
DAT typing: C3d only	Positive with anti-C3d reagent, negative with anti-IgG	Cold agglutinin disease, paroxysmal cold hemoglobinuria, some drug reactions; can also be a nonspecific finding in hospital patients.
Indirect Coombs (IAT, antibody screen), negative	No agglutination with screening cells	No clinically significant red cell antibodies detected; the standard result at the first prenatal visit and before transfusion.
IAT positive in pregnancy, anti-D titer	1:4 to 1:8 usually followed monthly; 1:16 or more (some centers 1:32) is the critical titer	At or above the critical titer, the fetus is monitored by middle cerebral artery Doppler ultrasound for anemia. Anti-K (Kell) is followed regardless of titer because it suppresses fetal red cell production.
IAT positive after Rh immunoglobulin	Weak anti-D, usually titer 1:4 or less, for up to 12 weeks	Passive antibody from the injection, not sensitization; expected after the 28-week dose and after delivery.

Positive Coombs test

A positive direct Coombs test means antibody, complement or both are attached to your red cells. In an adult the first question is whether those coated cells are being destroyed. If hemoglobin is falling, haptoglobin is low, LDH and indirect bilirubin are high and reticulocytes are rising, the diagnosis is immune hemolytic anemia, and the pattern of the typing helps: IgG (with or without C3d) points to warm autoimmune hemolytic anemia, which may be primary or secondary to lupus, lymphoma, chronic lymphocytic leukemia, infection, a drug or a recent transfusion; C3d alone points to cold agglutinin disease, often after mycoplasma pneumonia or mononucleosis or in association with a low-grade lymphoma. If all the hemolysis markers are normal, the positive test is an incidental finding and is common, particularly in hospital patients and anyone recently given intravenous immunoglobulin or Rh immunoglobulin.

In a newborn, a positive direct Coombs test on cord blood means maternal IgG has crossed the placenta and coated the baby's cells. In the United States today the usual reason is ABO incompatibility: a group O mother carries naturally occurring anti-A and anti-B, and about 15 to 20 percent of pregnancies are ABO-mismatched, though only a minority of those babies test positive and fewer still develop significant hemolysis. Rh (anti-D) disease is now uncommon because of routine Rh immunoglobulin but is more severe when it occurs. Either way, the baby is at higher risk of jaundice in the first 24 to 72 hours, so bilirubin is checked early and often, and the 2022 American Academy of Pediatrics guideline treats a positive DAT with hemolysis as a risk factor that lowers the threshold for phototherapy. Most Coombs-positive newborns need nothing more than monitoring and, if needed, light therapy.

A positive indirect Coombs test in pregnancy means you have made an antibody to a red cell antigen you lack, usually from a previous pregnancy, miscarriage or transfusion. The antibody is identified and the father's or fetus's antigen status is determined, because the fetus is only at risk if it carries the antigen. Anti-D, anti-c and anti-K are the antibodies most likely to cause hemolytic disease of the fetus and newborn; anti-E, anti-Fya and anti-Jka occasionally do; anti-Lewis, anti-M, anti-P1 and most others essentially never do. Risk is followed by titers every 2 to 4 weeks and, above the critical titer, by ultrasound Doppler of the fetal brain artery, which detects anemia non-invasively. A positive screen that turns out to be passive anti-D from a recent Rh immunoglobulin injection is expected and needs no follow-up.

Common causes

Warm autoimmune hemolytic anemia
IgG antibodies, usually against Rh-type proteins, coat red cells that are then removed by the spleen. About half the cases are primary; the rest accompany lupus, chronic lymphocytic leukemia, lymphoma, immunodeficiency, inflammatory bowel disease or follow a viral infection. DAT shows IgG, often with C3d.
Cold agglutinin disease and paroxysmal cold hemoglobinuria
IgM antibodies bind in the cooler peripheral circulation and fix complement, leaving C3d on the cells. Triggered by Mycoplasma pneumoniae, Epstein-Barr virus or an underlying lymphoma in adults, and by viral infections in children (paroxysmal cold hemoglobinuria). DAT shows C3d only.
Drug-induced immune hemolysis
Cephalosporins (ceftriaxone, cefotetan), piperacillin, penicillin, methyldopa, fludarabine, NSAIDs, quinine, oxaliplatin and immune checkpoint inhibitors can induce antibodies; the DAT becomes positive days to weeks after starting and usually clears within weeks of stopping.
Hemolytic transfusion reaction
An acute reaction to incompatible blood, or a delayed reaction 3 to 14 days later when a previously undetectable antibody re-forms. The DAT is positive, often with a mixed-field pattern because only the transfused cells are coated.
Hemolytic disease of the fetus and newborn (ABO or Rh)
Maternal anti-A or anti-B (group O mothers) or anti-D, anti-c or anti-K cross the placenta. ABO disease is common and usually mild; Rh disease is now rare but can cause severe anemia and jaundice.
Passive antibody: Rh immunoglobulin, IVIG, plasma or platelet transfusions
Antibodies given therapeutically coat cells harmlessly. Rh immunoglobulin to the mother can produce a weakly positive DAT in the baby; high-dose IVIG frequently produces a positive DAT in the recipient.
Lupus, lymphoma, chronic lymphocytic leukemia and HIV
Immune dysregulation produces red cell antibodies with or without hemolysis; up to a third of people with lupus or CLL have a positive DAT at some point.
After stem cell or solid organ transplant
Donor lymphocytes carried in the graft make antibodies against the recipient's red cells (passenger lymphocyte syndrome), typically 1 to 3 weeks after transplant.
Nonspecific binding and laboratory artifact
Very high serum globulins (myeloma, chronic infection), sickle cell disease, some monoclonal antibody drugs (daratumumab interferes with the indirect test in particular), and sample handling problems can produce weak positives in the absence of any immune hemolysis.

Symptoms that can go with it

None when the positive test is incidental or passive; many positive results are found in people who feel well
Fatigue, breathlessness, dizziness and pallor as hemoglobin falls with active hemolysis
Jaundice (yellow eyes or skin) and dark urine
Fingers, toes, nose or ears turning blue or painful in the cold, and dark urine after cold exposure, with cold agglutinin disease
Fever, chills, back pain and anxiety during or soon after a transfusion
In newborns: jaundice appearing within the first 24 hours, poor feeding, sleepiness or pallor, which need prompt bilirubin testing
An enlarged spleen or swollen lymph nodes when lymphoma or leukemia is the underlying cause

Read it alongside

Haptoglobin — low or undetectable when coated cells are actually being destroyed; normal haptoglobin with a positive DAT suggests an incidental or passive finding.
LDH and indirect (unconjugated) bilirubin — both rise with hemolysis; the bilirubin level drives decisions in newborns.
Reticulocyte count — rises as the marrow compensates; a low reticulocyte count with hemolysis is worrying and may indicate the marrow is also under attack.
Hemoglobin and MCHC — show the degree of anemia; a high MCHC and spherocytes on the smear are typical of warm autoimmune hemolysis.
Blood smear — spherocytes point to warm antibodies, red cell clumping on the slide to cold agglutinins, fragments to a non-immune cause.
Blood type (ABO and Rh) of mother and baby — explains most positive newborn tests; a group O mother with an A or B baby is the usual setting.
Antibody identification panel and titer — tell you which antibody is present and, in pregnancy, whether it is one that can harm the fetus and how strong it is.
ANA, immunoglobulins, CT or flow cytometry when indicated — a positive DAT with hemolysis in an adult prompts a search for lupus, lymphoma or CLL.

What usually happens next

In an adult with a positive direct Coombs test, the next tests are a CBC, reticulocyte count, haptoglobin, LDH, bilirubin and a blood smear to establish whether hemolysis is happening; if it is not, the result is noted and usually repeated in a few weeks.
If hemolysis is confirmed, expect a review of every medicine and transfusion in the past 3 months, DAT typing (IgG versus C3d), and often a search for an underlying condition with ANA, immunoglobulins and sometimes imaging or flow cytometry; treatment is decided by a hematologist and depends on the type.
For a newborn with a positive DAT, expect a bilirubin measurement within hours and repeat checks over the first days; most babies need observation only, some need phototherapy, and very few need more. Ask what bilirubin level would trigger treatment for your baby's age in hours.
For a positive antibody screen in pregnancy, expect antibody identification, a titer, testing of the father (or cell-free fetal DNA) for the relevant antigen, and repeat titers every 2 to 4 weeks; above the critical titer, referral for fetal Doppler ultrasound.
Before any future transfusion, tell the blood bank about a past positive antibody screen; antibodies can fall below detection and still cause a delayed reaction, so a record matters more than a current negative.

Diet, lifestyle and natural levers with evidence

What can move DAT / IAT once the cause is known. Nothing here replaces finding the cause.

Keep warm if you have cold agglutinins

Moderate evidence

Cold agglutinins bind red cells below about 30 to 32 °C, which is the temperature of fingers, toes and ears in cool air. Observational series and consensus guidelines agree that avoiding cold exposure, warming intravenous fluids and transfused blood, and dressing hands, feet and face warmly reduce hemolytic episodes and acrocyanosis in cold agglutinin disease. This does not change the DAT itself, which stays positive, but it reduces how much hemolysis the antibody causes.

Folic acid during active hemolysis

Moderate evidence

Immune hemolysis increases red cell turnover several-fold and depletes folate stores within weeks; hematology consensus recommendations include 1 mg of folic acid daily while hemolysis is active to prevent a superimposed megaloblastic anemia and to support the reticulocyte response. It supports recovery of the hemoglobin; it has no effect on the antibody or the test result.

Check vitamin B12 first, since folic acid can mask B12 deficiency.

Report recent transfusions, immunoglobulin and Rh immunoglobulin before testing

Strong evidence

Intravenous immunoglobulin produces a positive DAT in a large share of recipients, Rh immunoglobulin produces a weak passive anti-D on the indirect test for up to 12 weeks, and a transfusion within the past 3 months can produce a mixed-field DAT. None of these is sensitization or autoimmune disease, but each is routinely misread when the history is missing. Nothing dietary or herbal changes a Coombs result; an accurate history is the one thing that changes how it is interpreted.

Review medicines that induce red cell antibodies

Moderate evidence

Drug-induced immune hemolytic anemia is estimated at about 1 per million people per year, with cephalosporins (especially ceftriaxone and cefotetan) and piperacillin responsible for most recent cases, and the DAT usually becomes negative within days to weeks of stopping the culprit. If your DAT turned positive after starting a new antibiotic, anti-inflammatory, antimalarial or cancer drug, that timing is the most useful piece of information you can give your clinician; do not stop a prescribed medicine without discussing it.

When to see a clinician promptly

A positive Coombs test with breathlessness, a racing heart, chest pain, fainting or confusion: rapid hemolysis can drop hemoglobin dangerously within days and needs same-day assessment.
Dark or cola-colored urine, yellow eyes, fever or back pain during or within two weeks after a blood transfusion.
A newborn whose skin or eyes look yellow within the first 24 hours, who is very sleepy, feeding poorly, arching the back or has a high-pitched cry: same-day assessment, since very high bilirubin can injure the brain.
In pregnancy with a known red cell antibody: reduced fetal movements, or any rise in titer to 1:16 or above, which should prompt specialist referral for fetal monitoring.
Fingers or toes turning white, blue or painful in the cold together with anemia, which suggests cold agglutinin disease.
A positive test with persistent fatigue, night sweats, weight loss, swollen glands or an enlarged spleen, which raises the possibility of an underlying lymphoma or lupus.

Frequently asked questions

What does a positive Coombs test mean?

A positive direct Coombs test means antibodies or complement proteins are attached to your red blood cells; a positive indirect Coombs test means your blood contains antibodies against red cell antigens you do not have. In adults the direct test is positive in autoimmune hemolytic anemia, drug reactions and transfusion reactions, but also in many people with no red cell destruction at all, so it is read with haptoglobin, LDH, bilirubin and a reticulocyte count. In newborns it means the mother's antibodies have coated the baby's cells, and in pregnancy a positive indirect test means an antibody that needs identifying and following.

What is the difference between a direct and an indirect Coombs test?

The direct test (DAT) is done on your red cells and asks whether antibody is already bound to them inside your body; it is the test for immune hemolysis and for hemolytic disease of the newborn. The indirect test (IAT, antibody screen) is done on your plasma and asks whether free antibodies are present that could react with someone else's red cells; it is the test used before transfusion and at prenatal visits. A person can be positive on one and negative on the other.

My newborn has a positive Coombs test. Is it serious?

Usually not. Most positive results in US newborns come from ABO incompatibility, where a group O mother's natural anti-A or anti-B antibodies have crossed the placenta; the hemolysis is typically mild. The main consequence is a higher chance of jaundice in the first two to three days, so bilirubin is measured early and repeated, and some babies need phototherapy. Rh incompatibility and antibodies such as anti-K cause more severe hemolysis but are much less common now that Rh immunoglobulin is routine. A positive test with normal bilirubin and a stable hemoglobin needs observation only.

What does a positive indirect Coombs test in pregnancy mean?

It means you have made an antibody against a red cell antigen, usually from a previous pregnancy, miscarriage or transfusion, and the lab will identify which one. Whether it matters depends on the antibody and on whether the baby carries the antigen. Anti-D, anti-c and anti-K are the ones most likely to cause fetal anemia and are followed with titers every 2 to 4 weeks; an anti-D titer of 1:16 or higher (1:32 in some centers), or anti-K at any titer, leads to ultrasound Doppler monitoring of the fetus. Many antibodies, such as anti-Lewis and anti-M, do not cause fetal disease at all. If you received Rh immunoglobulin recently, a weak positive is the injection, not sensitization.

Can you have a positive Coombs test and no hemolysis?

Yes, and it is common. Between 1 in 1,000 and 1 in 14,000 healthy blood donors have a positive direct Coombs test, and 1 to 15 percent of hospitalized patients do, most without any red cell destruction. Causes include recent intravenous immunoglobulin or Rh immunoglobulin, high globulin levels, lupus, chronic lymphocytic leukemia, HIV, some medicines and nonspecific binding. If hemoglobin, haptoglobin, LDH, bilirubin and reticulocytes are normal, the result is noted and repeated later rather than treated.

Can the Coombs test be negative in autoimmune hemolytic anemia?

In about 5 to 10 percent of cases, yes. The antibody may be present at a level below what the standard reagent detects, or it may be IgA or a low-affinity IgG that the routine test misses. When the clinical picture strongly suggests immune hemolysis despite a negative DAT, reference laboratories can run more sensitive methods such as column agglutination, flow cytometry or anti-IgA reagents.

Which medications cause a positive Coombs test?

Cephalosporin antibiotics, particularly ceftriaxone and cefotetan, and piperacillin account for most recent cases of drug-induced immune hemolysis. Penicillin, methyldopa, fludarabine, NSAIDs such as diclofenac, quinine, oxaliplatin, levodopa and immune checkpoint inhibitors are also documented. High-dose intravenous immunoglobulin and Rh immunoglobulin produce positive results by coating cells passively rather than by inducing antibodies. The test usually turns negative within days to weeks of stopping the drug.

How long does a Coombs test stay positive?

It depends on the cause. Passive antibodies from Rh immunoglobulin or IVIG clear within about 4 to 12 weeks. Drug-induced positives usually resolve within weeks of stopping the drug. In a newborn with ABO incompatibility the maternal antibody is gone within 2 to 3 months. In autoimmune hemolytic anemia the DAT can stay positive for months or years, even in remission, and a persistently positive test with normal hemolysis markers does not by itself need treatment.

References

Coombs test. MedlinePlus Medical Encyclopedia, US National Library of Medicine (2023)
Zantek ND, Koepsell SA, Tharp DR Jr, Cohn CS. The direct antiglobulin test: a critical step in the evaluation of hemolysis. American Journal of Hematology (2012)
Parker V, Tormey CA. The direct antiglobulin test: indications, interpretation, and pitfalls. Archives of Pathology and Laboratory Medicine (2017)
Berentsen S, Barcellini W. Autoimmune hemolytic anemias. New England Journal of Medicine (2021)
Jäger U, Barcellini W, Broome CM, et al.. Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting. Blood Reviews (2020)
Hill QA, Stamps R, Massey E, et al.; British Society for Haematology. Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia. British Journal of Haematology (2017)
Garratty G. Drug-induced immune hemolytic anemia. Hematology, American Society of Hematology Education Program (2009)
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 192: Management of alloimmunization during pregnancy. Obstetrics and Gynecology (2018)
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 181: Prevention of Rh D alloimmunization. Obstetrics and Gynecology (2017)
Kemper AR, Newman TB, Slaughter JL, et al.. Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics (2022)
Dinesh D. Review of positive direct antiglobulin tests found on cord blood sampling. Journal of Paediatrics and Child Health (2005)
Autoimmune hemolytic anemia. Merck Manual Professional Version (2024)

Related markers

Related conditions

Evidence guides

Worried about your number?

Ask AskMN what your DAT / IAT result could mean in the context of your other results, symptoms and medications. Free, unlimited, no account needed.

Ask about my DAT / IAT

This page is educational and is not medical advice or a diagnosis. Lab results have to be interpreted together with your history, symptoms and other results by a clinician who knows you. Do not start or stop a supplement to change a lab value before the cause is known.